收藏切换
Research progress on sodium-glucose linked transporter 2 inhibitors in the treatment of heart failure
收藏切换
Yue MING1, Nianxi YU2, Xingyun HOU2, Xia TAO2, *
World Clinical Drug | 2022, 43(6) : 643 - 650
Less
收藏切换
World Clinical Drug | 2022, 43(6): 643-650
• Topic •
Research progress on sodium-glucose linked transporter 2 inhibitors in the treatment of heart failure
Full
Yue MING1, Nianxi YU2, Xingyun HOU2, Xia TAO2, *
Affiliations
  • 1.Department of Pharmacy, Army Medical Center of Chinese People's Liberation Army, Chongqing 400042, China
  • 2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China
Published: 2022-06-10 doi: 10.13683/j.wph.2022.06.001
Outline
收藏切换

Patients with heart failure (HF) have a higher risk of death, and diabetes mellitus (DM) is an important risk factor for HF. Sodium-glucose linked transporter 2 (SGLT2) inhibitor, as a new anti-hyperglycemia drug in recent years, has been proved to prevent cardiovascular events and improve the prognosis of patients with HF with reduced ejection fraction (HFrEF), and reduce the risk of HF hospitalization and cardiovascular death. This benefit is consistent in patients with or without DM. This article reviewed the previous literature on the effects of SGLT2 inhibitors on cardiovascular outcomes, especially on HF, in order to provide references for clinical medication.

sodium-glucose linked transporter 2 inhibitor  /  heart failure  /  diabetes mellitus  /  cardiovascular outcome
明月, 余年喜, 侯幸赟, 陶霞. 钠-葡萄糖耦联转运体2抑制剂治疗心力衰竭的研究进展. 世界临床药物, 2022 , 43 (6) : 643 -650 . DOI: 10.13683/j.wph.2022.06.001
Yue MING, Nianxi YU, Xingyun HOU, Xia TAO. Research progress on sodium-glucose linked transporter 2 inhibitors in the treatment of heart failure[J]. World Clinical Drug, 2022 , 43 (6) : 643 -650 . DOI: 10.13683/j.wph.2022.06.001
Year 2022 volume 43 Issue 6
14
5
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.06.001
  • Receive Date:2021-12-01
  • Online Date:2026-11-19
  • Published:2022-06-10
Article Data
Affiliations
History
  • Received:2021-12-01
  • Revised:2022-04-12
Funding
Affiliations
    1.Department of Pharmacy, Army Medical Center of Chinese People's Liberation Army, Chongqing 400042, China
    2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.06.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT